Details of issuance or disposal
Exercise status of warrants with exercise price adjustment clauses (monthly report)
1,410,000 new shares; 0 treasury shares transferred
3.25% (1,410,000 shares issued across all series combined / 43,399,118 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of warrants with exercise price adjustment clauses (monthly report) |
| Number of shares to be issued or disposed of | 1,410,000 new shares; 0 treasury shares transferred |
| Dilution Rate | 3.25% (1,410,000 shares issued across all series combined / 43,399,118 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 43,399,118 shares (as of the end of the month preceding the target month, including 125 treasury shares) → Not disclosed |
| Exercise price | The exercise prices in October 2026 were ¥99, ¥95, ¥94, ¥88, ¥85, ¥84, ¥83 and ¥82. Details and the floor price under the adjustment provision: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100,000 units; unexercised as of 5 October 2026: 100,000 units; exercised during the target month: 14,100 units; unexercised at the end of the target month: 85,900 units |
| Procedures under the Corporate Code of Conduct | Report on compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Timing 5 October 2026 / Type Series 14 Stock Acquisition Rights (with an exercise price adjustment provision) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the exercise status for October 2026.